UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: DiklofenakOrifarm25Enterotablett-SE-PLC-MPD-BBDL

Diklofenak Orifarm 25 mg enterotablett

MPID: SE-100002342-00019694
EURDID: 1048

Full name: Diklofenak Orifarm 25 mg enterotablett

- Scientific name part: Diklofenak Orifarm

- Strength part: 25 mg

- Pharmaceutical dose form part: enterotablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Gastro-resistant tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000096906 diclofenac

Marketing Authorisation 1 of 1

Authorisation number: 19694

Region: Kingdom of Sweden

Marketing authorisation holder: Orifarm Generics A/S

Identifier:

  • LOC-100005206

Status: Valid (2005-05-27)

Package 1 of 1

PCID:

Description:
Blister, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 10 Blister (PolyVinyl Chloride) (PolyVinylidene Chloride) (Aluminium)

Containing: 100 Tablet

Manufactured Item

Dose form: Gastro-resistant tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Diclofenac sodium

Presentation strength: 25 milligram(s) / 1 tablet

Reference strength:
diclofenac 20.7 milligram(s) / 1 tablet

Administrable Product (1 of 1)

Dose form: Gastro-resistant tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Diclofenac sodium

Presentation strength: 25 milligram(s) / 1 tablet

Reference strength:
diclofenac 20.7 milligram(s) / 1 tablet